Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy.

Prediction of risk of disease recurrence by genome-wide cDNA microarray analysis in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy. Int J Oncol. 2007 Aug; 31(2):313-22.

View in: PubMed

subject areas

Adult
Antineoplastic Agents
Benzamides
Cluster Analysis
Female
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Genome, Human
Humans
Imatinib Mesylate
Male
Middle Aged
Piperazines
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prognosis
Pyrimidines
Recurrence
Risk

authors with profiles

Yusuke Nakamura